Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market [2010-2019]

1
Investigation Report on China Piperacillin Sodium
and Tazobactam Sodium Market 2010-2019
Market Reports On China
http//www.marketreportsonchina.com
2
Summary

• Piperacillin sodium and tazobactam sodium is the
  compound drug of piperacillin sodium and
  tazobactam sodium, the former being
  semi-synthesized broad-spectrum penicillin while
  the latter being ß-lactamase inhibitor.
  Tazobactam sodium can prevent piperacillin from
  the ß-lactamase hydrolysis of some drug-resistant
  bacteria so as to maintain piperacillins
  antimicrobial activity or even expand its
  spectrum. The injection product of Piperacillin
  sodium and tazobactam sodium (piperacillin sodium
  and tazobactam sodium for injection) is often
  used in the clinic.
• Since its first marketing in France in 1992,
  piperacillin sodium and tazobactam sodium has
  entered the US, mainland Europe, Japan and
  Singapore. According to market survey,
  piperacillin sodium and tazobactam sodium
  develops fast after entering China in Oct. 1998,
  annual sales value rising from less than CNY 2
  million in 2005 to CNY 1.064 billion in 2014 and
  CAGR during this period reaching 22.2.

Scope The report provides in-depth market
analysis, information and insights, including
? A detailed coverage of the travel and
tourism industry in China ? A comprehensive
analysis of the airlines market in China ?
Profile of the top airlines operating in China

3

• Wyeth Pharmaceutical Co., Ltd (US), Qilu
  Pharmaceutical Co., Ltd, North China
  Pharmaceutical Group Corporation, Zhejiang
  Anglikang Pharmaceutical Co., Ltd and United
  Laboratories occupy the majority of the Chinese
  market, among which Wyeth Pharmaceutical Co., Ltd
  (US) has the largest market share of about 36
  for sales value in 2014.
• Piperacillin sodium and tazobactam sodium has
  been widely applied in the clinic with efficacy
  being confirmed by the randomized controlled
  trials conducted by multiple centers at home and
  abroad. And it has been recommended by many
  domestic and foreign treatment guidelines as the
  first choice of the initial empirical therapy for
  hospital infection caused by unidentified
  pathogenic bacteria. The market size of
  piperacillin sodium and tazobactam sodium is
  expected to grow in China or in the whole world.

4
Readers can get at least the following
information from this report - market size of
piperacillin sodium and tazobactam sodium in
China - competitive landscape of piperacillin
sodium and tazobactam sodium in Chinese market -
price of piperacillin sodium and tazobactam
sodium made by different enterprises in China -
market outlook of piperacillin sodium and
tazobactam sodium in China

5

• The author suggests the following groups of
  people purchase this report
• - manufacturers of anti-infectious drugs
• - investors/ research institutions interested in
  Chinese medicine market
• - any interest in the Chinese medicine market,
  please contact CRI for customized survey service

6
Table Of Content
1 Related Concepts of Piperacillin Sodium
Tazobactam Sodium 2 Market Profile of
Piperacillin Sodium and Tazobactam Sodium in
China 3 Survey on Sales Status of Piperacillin
Sodium and Tazobactam Sodium in China,
2010-2014 4 Survey on Market Share of Major
Manufacturers of Piperacillin Sodium and
Tazobactam Sodium in China, 2010-2014 5 Survey
on Dosage Forms of Piperacillin Sodium and
Tazobactam Sodium in China, 2010-2014 6
Reference Price of Piperacillin Sodium and
Tazobactam Sodium in Chinese Hospitals in
2014

7
To view the full Executive Summary and Table of
Contents, please visit Investigation Report
on China Piperacillin Sodium and Tazobactam
Sodium Market 2010-2019 Contact Us Market
Reports On ChinaContact No 91 2227810772,
27810773 Email id info_at_marketreportsonchina.co
m Website http//marketreportsonchina.com/